Meeting
2021 Gastrointestinal Cancers Symposium
Predictors of uptake of aspirin (ASA) chemoprevention in Lynch syndrome (LS).
Authors
Michael J. Hall
Fox Chase Cancer Center, Philadelphia, PA
Michael J. Hall , Margie Clapper , Wen-Chi J Chang , Yana Chertock , Minhhuyen J Nguyen
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session: Colorectal Cancer
Track
Colorectal Cancer
Sub Track
Prevention, Screening, and Hereditary Cancers
Citation
J Clin Oncol 39, 2021 (suppl 3; abstr 49)
DOI
10.1200/JCO.2021.39.3_suppl.49
Abstract #
49
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Prevalence and predictors of aspirin/NSAID use among patients with Lynch syndrome (LS).
First Author: Sachi Singhal
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Attitudes toward prevention options in Lynch syndrome (LS): Comparing frameshift peptide vaccination (FSPVAX), colonoscopy (COLO), and aspirin (ASA) chemoprevention.
First Author: Michael J. Hall
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Perceptions of cancer prevention options for Lynch syndrome (LS) in a multi-national convenience sample.
First Author: Michael J. Hall
Poster
2022 ASCO Annual Meeting
Predictors of use of prevention strategies among women at high-risk for breast cancer.
First Author: Kara Landry